Genome-wide assessment of the carriers involved in the cellular uptake of drugs: A model system in yeast

BMC Biology

Volumn 9, Issue , 2011, Pages

  Lanthaler, Karin ^a   Bilsland, Elizabeth ^b   Dobson, Paul D ^a   Moss, Harry J ^b   Pir, Pinar ^a,b   Kell, Douglas B ^a   Oliver, Stephen G ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANAVANINE; CARRIER PROTEIN; DRUG;

ARTICLE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DRUG SCREENING; GENE DELETION; GENETIC ASSOCIATION; GENETICS; GENOMICS; HUMAN; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CANAVANINE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DRUG EVALUATION, PRECLINICAL; GENE DELETION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MEMBRANE TRANSPORT PROTEINS; PHARMACEUTICAL PREPARATIONS; POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE;

EID: 80054813491     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-9-70     Document Type: Article

References (73)

1. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov 2004, 3(8):711-716. 10.1038/nrd1470, 15286737.
2. Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007, 6(11):881-890. 10.1038/nrd2445, 17971784.
3. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001, 46(1-3):3-26. 10.1016/S0169-409X(00)00129-0, 11259830.
4. Sai Y. Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition. Drug Metab Pharmacokinet 2005, 20(2):91-99. 10.2133/dmpk.20.91, 15855719.
5. Dobson PD, Lanthaler K, Oliver SG, Kell DB. Implications of the dominant role of transporters in drug uptake by cells. Curr Top Med Chem 2009, 9(2):163-181. 10.2174/156802609787521616, 19200003.
6. Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat Rev Drug Discov 2008, 7(3):205-220. 10.1038/nrd2438, 18309312.
7. Sai Y, Tsuji A. Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov Today 2004, 9(16):712-720. 10.1016/S1359-6446(04)03198-8, 15341785.
8. Carroll PM, Dougherty B, Ross-Macdonald P, Browman K, FitzGerald K. Model systems in drug discovery: chemical genetics meets genomics. Pharmacol Ther 2003, 99(2):183-220. 10.1016/S0163-7258(03)00059-7, 12888112.
9. Giaever G. A chemical genomics approach to understanding drug action. Trends Pharmacol Sci 2003, 24(9):444-446. 10.1016/S0165-6147(03)00225-6, 12967766.
10. Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotech 2004, 22(1):62-69.
11. Brenner C. Chemical genomics in yeast. Genome Biol 2004, 5(9):240. 10.1186/gb-2004-5-9-240, 522863, 15345040.
12. Holland S, Lodwig E, Sideri T, Reader T, Clarke I, Gkargkas K, Hoyle D, Delneri D, Oliver S, Avery S. Application of the comprehensive set of heterozygous yeast deletion mutants to elucidate the molecular basis of cellular chromium toxicity. Genome Biol 2007, 8(12):R268. 10.1186/gb-2007-8-12-r268, 2246270, 18088421.
13. Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, Hinshaw JC, Garnier P, Prestwich GD, Leonardson A, Garrett-Engele P, Rush CM, Bard M, Schimmack G, Phillips JW, Roberts CJ, Shoemaker DD. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004, 116(1):121-137. 10.1016/S0092-8674(03)01035-3, 14718172.
14. Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, Chua G, Sopko R, Brost RL, Ho CH, Wang J, Ketela T, Brenner C, Brill JA, Fernandez GE, Lorenz TC, Payne GS, Ishihara S, Ohya Y, Andrews B, Hughes TR, Frey BJ, Graham TR, Andersen RJ, Boone C. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006, 126(3):611-625. 10.1016/j.cell.2006.06.040, 16901791.
15. Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Nat Acad Sci USA 2002, 99(22):14298-14302. 10.1073/pnas.162491399, 137878, 12370430.
16. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, Anderson K, Andre B, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002, 418(6896):387-391. 10.1038/nature00935, 12140549.
17. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, Chu AM, Jordan MI, Arkin AP, Davis RW. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Nat Acad Sci USA 2004, 101(3):793-798. 10.1073/pnas.0307490100, 321760, 14718668.
18. Delneri D, Colson I, Grammenoudi S, Roberts IN, Louis EJ, Oliver SG. Engineering evolution to study speciation in yeasts. Nature 2003, 422(6927):68-72. 10.1038/nature01418, 12621434.
19. Delneri D, Hoyle DC, Gkargkas K, Cross EJM, Rash B, Zeef L, Leong H-S, Davey HM, Hayes A, Kell DB, Griffith GW, Oliver SG. Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures. Nat Genet 2008, 40(1):113-117. 10.1038/ng.2007.49, 18157128.
20. Smith AM, Heisler LE, Mellor J, Kaper F, Thompson MJ, Chee M, Roth FP, Giaever G, Nislow C. Quantitative phenotyping via deep barcode sequencing. Genome Res 2009, 19(10):1836-1842. 10.1101/gr.093955.109, 2765281, 19622793.
21. Dobson PD, Patel Y, Kell DB. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 2009, 14(1-2):31-40. 10.1016/j.drudis.2008.10.011, 19049901.
22. Lemontt JF. Pathways of ultraviolet mutability in Saccharomyces cerevisiae.III. Genetic analysis and properties of mutants resistant to ultraviolet-induced forward mutation. Mutat Res 1977, 43(2):179-204. 10.1016/0027-5107(77)90003-3, 325400.
23. Grenson M, Mousset M, Wiame JM, Bechet J. Multiplicity of the amino acid permeases in Saccharomyces cerevisiae. I. Evidence for a specific arginine-transporting system. Biochim Biophys Acta 1966, 127(2):325-338. 10.1016/0304-4165(66)90387-4, 5964977.
24. Guetsova ML, Lecoq K, Daignan-Fornier B. The isolation and characterization of Saccharomyces cerevisiae mutants that constitutively express purine biosynthetic genes. Genetics 1997, 147(2):383-397. 1208165, 9335580.
25. Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potentially inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998, 253(2):295-299. 10.1006/bbrc.1998.9729, 9878531.
26. Belenky PA, Moga TG, Brenner C. Saccharomyces cerevisiae YOR071C encodes the high affinity nicotinamide riboside transporter Nrt1. J Biol Chem 2008, 283(13):8075-8079. 10.1074/jbc.C800021200, 18258590.
27. Enjo F, Nosaka K, Ogata M, Iwashima A, Nishimura H. Isolation and characterization of a thiamin transport gene, THI10, from Saccharomyces cerevisiae. J Biol Chem 1997, 272(31):19165-19170. 10.1074/jbc.272.31.19165, 9235906.
28. Fry DW, Jackson RC. Biological and biochemical properties of new anticancer folate antagonists. Cancer Metastasis Rev 1987, 5(3):251-270. 10.1007/BF00047000, 3549036.
29. Stoops JK, Wakil SJ. Yeast fatty acid synthetase: structure-function relationship and nature of the beta-ketoacyl synthetase site. Proc Natl Acad Sci USA 1980, 77(8):4544-4548. 10.1073/pnas.77.8.4544, 349880, 7001460.
30. Cheng Q, Michels CA. MAL11 and MAL61 encode the inducible high-affinity maltose transporter of Saccharomyces cerevisiae. J Bacteriol 1991, 173(5):1817-1820. 207336, 1999393.
31. Relic B, Benoit V, Franchimont N, Ribbens C, Kaiser MJ, Gillet P, Merville MP, Bours V, Malaise MG. 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. J Biol Chem 2004, 279(21):22399-22403. 10.1074/jbc.M314118200, 15004016.
32. Sorensen LB, Levinson DJ. Clinical evaluation of benzbromarone: a new uricosuric drug. Arthritis Rheum 1976, 19(2):183-190. 10.1002/art.1780190209, 1259799.
33. Wagner R, de Montigny J, de Wergifosse P, Souciet JL, Potier S. The ORF YBL042 of Saccharomyces cerevisiae encodes a uridine permease. FEMS Microbiol Lett 1998, 159(1):69-75. 10.1111/j.1574-6968.1998.tb12843.x, 9485596.
34. Crespi MD, Ivanier SE, Genovese J, Baldi A. Mitoxantrone affects topoisomerase activities in human breast cancer cells. Biochem Biophys Res Commun 1986, 136(2):521-528. 10.1016/0006-291X(86)90471-7, 3010982.
35. Schreve JL, Sin JK, Garrett JM. The Saccharomyces cerevisiae YCC5 (YCL025c) gene encodes an amino acid permease, Agp1, which transports asparagine and glutamine. J Bacteriol 1998, 180(9):2556-2559. 107201, 9573211.
36. Mehdi SH, Brisbin DA, McBryde WA. The stability of porphyrin and metalloporphyrin molecular complexes in solution. Biochim Biophys Acta 1976, 444(2):407-415. 10.1016/0304-4165(76)90384-6, 971415.
37. Protchenko O, Shakoury-Elizeh M, Keane P, Storey J, Androphy R, Philpott CC. Role of PUG1 in inducible porphyrin and heme transport in Saccharomyces cerevisiae. Eukaryot Cell 2008, 7(5):859-871. 10.1128/EC.00414-07, 2394968, 18326586.
38. Hanson PK, Malone L, Birchmore JL, Nichols JW. Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine. J Biol Chem 2003, 278(38):36041-36050. 10.1074/jbc.M305263200, 12842877.
39. Kuo SC, Lampen JO. Tunicamycin-an inhibitor of yeast glycoprotein synthesis. Biochem Biophys Res Commun 1974, 58(1):287-295. 10.1016/0006-291X(74)90925-5, 4598444.
40. Kohno K, Normington K, Sambrook J, Gething MJ, Mori K. The promoter region of the yeast KAR2 (BiP) gene contains a regulatory domain that responds to the presence of unfolded proteins in the endoplasmic reticulum. Mol Cell Biol 1993, 13(2):877-890. 358971, 8423809.
41. Pomorski T, Lombardi R, Riezman H, Devaux PF, van Meer G, Holthuis JC. Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis. Mol Biol Cell 2003, 14(3):1240-1254. 10.1091/mbc.E02-08-0501, 151593, 12631737.
42. Martinez P, Persson BL. Identification, cloning and characterization of a derepressible Na+-coupled phosphate transporter in Saccharomyces cerevisiae. Mol Gen Genet 1998, 258(6):628-638. 10.1007/s004380050776, 9671031.
43. Shiraishi E, Inouhe M, Joho M, Tohoyama H. The cadmium-resistant gene, CAD2, which is a mutated putative copper-transporter gene (PCA1), controls the intracellular cadmium-level in the yeast S. cerevisiae. Curr Genet 2000, 37(2):79-86. 10.1007/s002940050013, 10743563.
44. Tenreiro S, Vargas RC, Teixeira MC, Magnani C, Sa-Correia I. The yeast multidrug transporter Qdr3 (Ybr043c): localization and role as a determinant of resistance to quinidine, barban, cisplatin, and bleomycin. Biochem Biophys Res Commun 2005, 327(3):952-959. 10.1016/j.bbrc.2004.12.097, 15649438.
45. Abe F, Usui K, Hiraki T. Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae. Biochemistry 2009, 48(36):8494-8504. 10.1021/bi900578y, 19670905.
46. Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, Kaplan J. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 1994, 76(2):403-410. 10.1016/0092-8674(94)90346-8, 8293473.
47. Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 1996, 271(5255):1552-1557. 10.1126/science.271.5255.1552, 8599111.
48. Nikawa J, Tsukagoshi Y, Yamashita S. Isolation and characterization of two distinct myo-inositol transporter genes of Saccharomyces cerevisiae. J Biol Chem 1991, 266(17):11184-11191.
49. Haase E, Servos J, Brendel M. Isolation and characterization of additional genes influencing resistance to various mutagens in the yeast Saccharomyces cerevisiae. Curr Genet 1992, 21(4-5):319-324. 10.1007/BF00351689, 1525860.
50. Paidhungat M, Garrett S. A homolog of mammalian, voltage-gated calcium channels mediates yeast pheromone-stimulated Ca2+ uptake and exacerbates the cdc1(Ts) growth defect. Mol Cell Biol 1997, 17(11):6339-6347. 232485, 9343395.
51. Honkanen RE. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett 1993, 330(3):283-286. 10.1016/0014-5793(93)80889-3, 8397101.
52. Yang QC, Shi WZ, Li R, Gan J. The antimalarial and toxic effect of artesunate on animal models. J Tradit Chin Med 1982, 2(2):99-103.
53. Ghaffarifar F. Leishmania major in vitro and in vivo anti-leishmanial effect of cantharidin. Exp Parasitol 2010, 126(2):126-129. 10.1016/j.exppara.2010.04.004, 20435039.
54. Courchesne WE, Ozturk S. Amiodarone induces a caffeine-inhibited, MID1-depedent rise in free cytoplasmic calcium in Saccharomyces cerevisiae. Mol Microbiol 2003, 47(1):223-234.
55. Stolz J, Hoja U, Meier S, Sauer N, Schweizer E. Identification of the plasma membrane H+-biotin symporter of Saccharomyces cerevisiae by rescue of a fatty acid-auxotrophic mutant. J Biol Chem 1999, 274(26):18741-18746. 10.1074/jbc.274.26.18741, 10373489.
56. Turoscy V, Cooper TG. Ureidosuccinate is transported by the allantoate transport system in Saccharomyces cerevisiae. J Bacteriol 1987, 169(6):2598-2600. 212131, 3294799.
57. Solans X, Ruiz-Ramirez L, Martinez A, Gasque L, Brianso JL. Structures of chloro(glycinato)(1,10-phenanthroline)copper(II) monohydrate (I) and aqua(1,10-phenanthroline)(L-phenylalaninato)copper(II) nitrate monohydrate (II). Acta Crystallogr C 1988, 44(Pt 4):628-631.
58. Dancis A, Yuan DS, Haile D, Askwith C, Eide D, Moehle C, Kaplan J, Klausner RD. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 1994, 76(2):393-402. 10.1016/0092-8674(94)90345-X, 8293472.
59. Conde de Felipe MM, Lehmann MM, Jerome ME, White MW. Inhibition of Toxoplasma gondii growth by pyrrolidine dithiocarbamate is cell cycle specific and leads to population synchronization. Mol Biochem Parasitol 2008, 157(1):22-31. 10.1016/j.molbiopara.2007.09.003, 2222652, 17976834.
60. Kell DB, Dobson PD, Oliver SG. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discov Today 2011, 16(15-16):704-714. 10.1016/j.drudis.2011.05.010, 21624498.
61. Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat Rev Drug Discov 2008, 7(3):205-220. 10.1038/nrd2438, 18309312.
62. Sai Y. Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition. Drug Metab Pharmacokinet 2005, 20(2):91-99. 10.2133/dmpk.20.91, 15855719.
63. Sai Y, Tsuji A. Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov Today 2004, 9(16):712-720. 10.1016/S1359-6446(04)03198-8, 15341785.
64. Dobson PD, Lanthaler K, Oliver SG, Kell DB. Implications of the dominant role of transporters in drug uptake by cells. Curr Top Med Chem 2009, 9(2):163-181. 10.2174/156802609787521616, 19200003.
65. Kell D. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics 2009, 2:2. 10.1186/1755-8794-2-2, 2672098, 19133145.
66. Eggeling L, Sahm H. New ubiquitous translocators: amino acid export by Corynebacterium glutamicum and Escherichia coli. Arch Microbiol 2003, 180(3):155-160. 10.1007/s00203-003-0581-0, 12879215.
67. Andre B, Scherens B. The yeast YBR235W gene encodes a homolog of the mammalian electroneutral Na(+)-(K+)-Cl-cotransporter family. Biochem Biophys Res Comm 1995, 217(1):150-153. 10.1006/bbrc.1995.2757, 8526903.
68. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srvivas R, Palsson BO. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 2007, 104:1777-1782. 10.1073/pnas.0610772104, 1794290, 17267599.
69. Ma Y, Yeh M, Yeh K-Y, Glass J. Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2006, 290(3):G417-422. 10.1152/ajpgi.00489.2005, 16474007.
70. Bailey PD, Boyd CA, Collier ID, George JP, Kellett GL, Meredith D, Morgan KM, Pettecrew R, Price RA. Affinity prediction for substrates of the peptide transporter PepT1. Chem Commun (Camb) 2006, 3:323-325.
71. Kell DB. The virtual human: towards a global systems biology of multiscale, distributed biochemical network models. IUBMB Life 2007, 59:689-695. 10.1080/15216540701694252, 17968707.
72. Pierce SE, Fung EL, Jaramillo DF, Chu AM, Davis RW, Nislow C, Giaever G. A unique and universal molecular barcode array. Nat Methods 2006, 3(8):601-603. 10.1038/nmeth905, 16862133.
73. Bilsland E, Pir P, Gutteridge A, Johns A, King RD, Oliver SG. Functional expression of parasite drug targets and their human orthologs in yeast. PLoS Negl Trop Dis 2011, 5(10):e1320. 10.1371/journal.pntd.0001320, 3186757, 21991399.